BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

AHF Denounces Moderna’s Backtracking on African mRNA Factory as a Blow to Global Health Equity

In a scathing rebuke, the AIDS Healthcare Foundation (AHF) has criticized Moderna for suspending its plans to build a state-of-the-art mRNA manufacturing f...

April 15, 2024 | News

YS Biopharma Reports Positive Phase 3 Results for Its PIKA Rabies Vaccine

YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturi...

April 10, 2024 | News

Clover Biopharmaceuticals Announces Promising Phase I Results for Its RSV Vaccine Candidate

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovat...

April 09, 2024 | News

Recbio and Rongsheng Biotech Sign Partnership for New Adjuvant Vaccine Project

Jiangsu Recbio Technology Co., Ltd. (hereafter referred to as Recbio; stock code: 02179.HK) and Shanghai Rongsheng Biotech Co.,Ltd.(hereafter referred...

March 27, 2024 | Company results

Altamira Therapeutics Partners with Univercells to Enhance mRNA Vaccine Delivery

Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company providing nanoparticle-based technology for...

March 26, 2024 | News

India Launches Pioneering Trials for MTBVAC TB Vaccine by Biofabri and Bharat Biotech to Revolutionize Global TB Prevention

Innovative Tuberculosis Vaccine, MTBVAC, Enters Clinical Trials in India In a major leap forward in the fight against tuberculosis (TB)—a deadly inf...

March 24, 2024 | News

SK bioscience Breaks Ground in Southeast Asia and Southern Hemisphere with 440,000 Dose Vaccine Export to Thailand

Company exported 440,000 doses to Thailand, marking its entry into the Southeast Asian market and the Southern Hemisphere market. Company has obtained m...

March 21, 2024 | News

New Phase 3 Trial Begins for Potential Tuberculosis Vaccine M72/AS01E

The Bill & Melinda Gates Medical Research Institute (Gates MRI) has initiated a large-scale Phase 3 trial to evaluate the effic...

March 20, 2024 | News

SK bioscience and Sanofi to Boost Global Vaccine Supply with Major Expansion of L HOUSE Manufacturing Plant

The company will expand its manufacturing plant, L HOUSE, with additional cGMP-level facility. The new space will serve as a production base for the pne...

March 08, 2024 | News

Naveris Inc. Launches Pioneering NAVigate-HPV Registry to Enhance HPV Cancer Diagnostics

-Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the launch of the NAVigate-HPV Registry. This innov...

March 04, 2024 | News

CATUG and Crystal Bio Launch Joint Lab for Advanced Nucleic Acid Analysis

CATUG, a distinguished global entity specializing in integrated nucleic acid and drug delivery CRDMO services, is combining capabilities with Crystal ...

February 25, 2024 | News

Everest Medicines Ends Collaboration with Providence, Gains Full Rights to mRNA Products

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization ...

February 19, 2024 | News

Preclinical Data Reveals Promising Long-Term Immune Response from PIV5-based Intranasal Lyme Disease Vaccine

The research showcases mice inoculated with this innovative vaccine exhibiting enduring neutralizing antibody responses, providing protection for up to 15...

February 16, 2024 | News

Brii Biosciences Secures Intellectual Property Rights for HBV Treatment from VBI Vaccines

Brii Biosciences Limited ("Brii Bio"), a leader in developing innovative treatments for diseases with significant unmet needs, has announced a strategic ac...

February 14, 2024 | News

Stay Connected